Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-UVEITIS: Actemra in Non-infectious Uveitis
NCT01717170Phase 2Unknown
- Sponsor
- University of Nebraska
- Start
- Mar 2013
- Primary completion
- Jun 2017
- Countries
- 1
01
Overview
A Phase 2 trial of tocilizumab in noninfectious uveitis (NIU), sponsored by University of Nebraska. Status: unknown.
02
Drugs
tocilizumab
03
Conditions
noninfectious uveitis (NIU)
Beyond the preview
Go deeper on NCT01717170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01717170.